TCL Archive In Brief: What’s In A Name? DRCCA Doesn’t Do It; O’Conor Says ICRDB Program Should Consider New Challenges October 3, 1980
TCL Archive The NCI director and acting FDA commissioner called for faster approval of cancer drugs in speech to FDA staff. October 21, 2005
TCL Archive ODAC Recommendation for Pertuzumab Signals FDA’s Resolve In Granting Accelerated Approvals September 20, 2013
